Results 181 to 190 of about 1,033,542 (310)

Role of Mast Cells and Their Mediators in Chronic Kidney Diseases. [PDF]

Int J Mol Sci
Tziastoudi M, Cholevas C, Eleftheriadis T, Stefanidis I, Theoharides TC.   +4 more
europepmc   +1 more source

Integrative therapeutic strategies in chronic kidney disease: from precision to regeneration

Dolores Javier Sánchez-González, Nayeli Isabel Trejo-Bahena, Enrique Méndez-Bolaina, Israel Ramírez-Sánchez, Elena de la Cruz Herrera-Cogco, Gabriela Gutiérrez-Salmeán   +5 more
openalex   +1 more source

FP069ROLE OF SOLUBLE FORM AND EXTRACELLULAR VESICLE (EV)-CARRIED CD40LIGAND (CD40L) AS BIOMARKER OF DISEASE ACTIVITY AND AS MEDIATOR OF MICROVASCULAR ENDOTHELIAL INJURY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY (AKI) AND IN END STAGE RENAL DISEASE (ESRD) PATIENTS [PDF]

, 2018
Marita Marengo, M. Migliori, Davide Medica, Vincenzo Panichi, Claudio Ronco, Vincenzo Cantaluppi   +5 more
openalex   +1 more source

Oral Dosed Organo‐Silica Nanoparticles Restore Glucose Homeostasis and β‐Cell Function in Diabetes Rats

Advanced Functional Materials, EarlyView.
An oral nanoplatform, MOP@T@D, which can maintain glucose homeostasis and restore islet β cells in diabetic rats is developed. It achieves efficient intestinal absorption and liver‐targeted delivery. The nanoparticle disintegrates only in response to hyperglycemia to release insulin on demand and provides antioxidant protection through selenoprotein ...
Chenxiao Chu, Mingli Wei, Che Bian, Xiaoshuang Bi, Yaxin Deng, Peifu Xiao, Jiansong Zhao, Yuying Wang, Haibing He, Jingxin Gou, Tian Yin, Xing Tang, Li Yang, Hongbo Zhang, Yu Zhang   +14 more
wiley   +1 more source

CRISPR and gene editing for kidney diseases: where are we? [PDF]

Clin Kidney J
D'Ambrosio V, Huimei C, Vo N, Siew K, Evans RDR, Freedman B, Pesce F.   +6 more
europepmc   +1 more source

Australian general practitioners’ current practice for chronic kidney disease (CKD) detection and management

, 2017
Marie Ludlow, Timothy H. Mathew, Timothy Usherwood, Shanthi Ramanathan, Ivor Katz, Katherine A. Fawcett, David W. Johnson   +6 more
openalex   +1 more source

P4796Secondary stroke prophylaxis in atrial fibrillations patients with chronic kidney disease: a nationwide cohort study [PDF]

, 2018
Mathias A. Christensen, E L Fosboel, Anders Nissen Bonde, J B Olesen, Gunnar Gislason, Christian Torp-Petersen, Anna Gundlund   +6 more
openalex   +1 more source

Synthetic Nanobiology Actuated Lipometabolic Cell Factory for Autologous Tumor Immunotherapy

Advanced Functional Materials, EarlyView.
FA plays a crucial role in the interaction between tumor cells and the tumor microenvironment, especially for the immune response. A biocatalytic immunoenhancement strategy is developed to boost antitumor immunity by FA metabolic orientation to ceramide. Through the design of this delicate catalytic immunoenhancement strategy, the synthetic nanobiology
Shoujie Zhao, Yejing Zhu, Hengchao Yu, Jun Zhu, Bo Wang, Yu Qiao, Zhimin Tian, Junlong Zhao, Lei Liu   +8 more
wiley   +1 more source

Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases. [PDF]

Front Immunol
Luo Y, Long M, Wu X, Zeng L.
europepmc   +1 more source

Review for "Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease: A systematic review and network meta‐analysis"

, 2022

openalex   +1 more source